{"id":4892,"date":"2023-06-05T08:01:00","date_gmt":"2023-06-05T06:01:00","guid":{"rendered":"https:\/\/www.icotec-medical.com\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/"},"modified":"2023-06-09T16:42:05","modified_gmt":"2023-06-09T14:42:05","slug":"2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system","status":"publish","type":"post","link":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/","title":{"rendered":"2023-06-01: Completion of 50 % patient enrollment for PMCF study with the KONG<sup>\u00ae<\/sup>-TL VBR System"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\"><strong>June 1, 2023 \u2013 Altstaetten, Switzerland \u2013 <\/strong>icotec ag is proud to announce the completion of 50 % patient enrollment for its ongoing multi-center post-market clinical follow-up (PMCF) study with the KONG<sup>\u00ae<\/sup>-TL VBR System.<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">This prospective, multi-center, PMCF is focused on investigating the performance and safety of the <a href=\"https:\/\/www.icotec-medical.com\/en-us\/implants\/kong-tl-vbr-system\/\">KONG<sup>\u00ae<\/sup>-TL VBR System<\/a> in patients requiring corpectomy procedures followed by vertebral body replacement in the thoracolumbar spine, for tumors or vertebral fractures. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Multiple European hospitals have confirmed patient enrollment in accordance with the study plan, with the anticipation of completing the enrollment process by mid-2024.<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full\"><img decoding=\"async\" width=\"853\" height=\"1024\" src=\"https:\/\/www.icotec-medical.com\/wp-content\/uploads\/2023\/06\/PMCF-853x1024-1.jpg\" alt=\"PCMF 2023\" class=\"wp-image-5885\" srcset=\"https:\/\/www.icotec-medical.com\/wp-content\/uploads\/2023\/06\/PMCF-853x1024-1.jpg 853w, https:\/\/www.icotec-medical.com\/wp-content\/uploads\/2023\/06\/PMCF-853x1024-1-250x300.jpg 250w, https:\/\/www.icotec-medical.com\/wp-content\/uploads\/2023\/06\/PMCF-853x1024-1-768x922.jpg 768w\" sizes=\"(max-width: 853px) 100vw, 853px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">We extend our gratitude to the dedicated staff at icotec and the study centers for their meticulous data collection and study administration over the planned 24-month follow-up period.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Our <a href=\"https:\/\/www.icotec-medical.com\/en-us\/implants\/kong-tl-vbr-system\/\">KONG<sup>\u00ae<\/sup>-TL VBR<\/a> expandable corpectomy cage is made from <a href=\"https:\/\/www.icotec-medical.com\/en-us\/blackarmor\/\">BlackArmor<sup>\u00ae<\/sup> Carbon\/PEEK<\/a> which provides artifact-reduced postoperative imaging combined with reliable osseointegration facilitated by our unique Ti-iT<sup>\u00ae<\/sup> titanium coating. Tumor patients further benefit from reliable radiation therapy planning and application thanks to our radiolucent material. Stay tuned as we eagerly anticipate sharing the initial results.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">About icotec ag<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Founded in 1999, icotec ag is a family-owned SME based in Altstaetten, Switzerland. icotec develops, manufactures, and distributes spinal implants made from radiolucent and artifact-free BlackArmor<sup>\u00ae<\/sup>. icotec\u2019s proprietary BlackArmor<sup>\u00ae<\/sup>&nbsp;material is made up of continuous carbon fibers combined with PEEK and is processed with icotec\u2019s unique manufacturing technology. With 20 years of clinical success and more than 50,000 implanted products, icotec ag is a pioneer in cutting-edge spinal tumor therapy. For further information, visit our website&nbsp;<a rel=\"noreferrer noopener\" href=\"http:\/\/www.icotec-medical.com\/\" target=\"_blank\">www.icotec-medical.com<\/a>&nbsp;or contact us at&nbsp;<a href=\"javascript:linkTo_UnCryptMailto('ocknvq,ogfkcBkeqvge\/ogfkecn0eqo');\">&#x6d;&#101;&#100;i&#x61;&#x40;&#105;c&#x6f;&#x74;&#101;c&#x2d;&#x6d;&#101;d&#x69;&#x63;&#97;l&#x2e;&#x63;&#111;m<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>June 1, 2023 \u2013 Altstaetten, Switzerland \u2013 icotec ag is proud to announce the completion of 50 % patient enrollment for its ongoing multi-center post-market clinical follow-up (PMCF) study with the KONG\u00ae-TL VBR System. This prospective, multi-center, PMCF is focused on investigating the performance and safety of the KONG\u00ae-TL VBR System in patients requiring corpectomy [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":4883,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4892","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-unkategorisiert"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Completion of 50% for the PMCF study with the KONG\u00ae-TL VBR system | icotec<\/title>\n<meta name=\"description\" content=\"icotec ag is proud to announce the completion of 50 % patient enrollment for its ongoing multi-center post-market clinical follow-up (PMCF) study with the KONG\u00ae-TL VBR System.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Completion of 50% for the PMCF study with the KONG\u00ae-TL VBR system | icotec\" \/>\n<meta property=\"og:description\" content=\"icotec ag is proud to announce the completion of 50 % patient enrollment for its ongoing multi-center post-market clinical follow-up (PMCF) study with the KONG\u00ae-TL VBR System.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/\" \/>\n<meta property=\"og:site_name\" content=\"icotec\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-05T06:01:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-09T14:42:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.icotec-medical.com\/wp-content\/uploads\/2023\/06\/PMCF-scaled-e1686321396601.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2131\" \/>\n\t<meta property=\"og:image:height\" content=\"1068\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nicole Heim\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicole Heim\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/\"},\"author\":{\"name\":\"Nicole Heim\",\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/#\\\/schema\\\/person\\\/ead9dbae0b7c930f3c8f361f35835f9b\"},\"headline\":\"2023-06-01: Completion of 50 % patient enrollment for PMCF study with the KONG\u00ae-TL VBR System\",\"datePublished\":\"2023-06-05T06:01:00+00:00\",\"dateModified\":\"2023-06-09T14:42:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/\"},\"wordCount\":279,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.icotec-medical.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/PMCF-scaled-e1686321396601.jpg\",\"articleSection\":[\"Unkategorisiert\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/\",\"url\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/\",\"name\":\"Completion of 50% for the PMCF study with the KONG\u00ae-TL VBR system | icotec\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.icotec-medical.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/PMCF-scaled-e1686321396601.jpg\",\"datePublished\":\"2023-06-05T06:01:00+00:00\",\"dateModified\":\"2023-06-09T14:42:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/#\\\/schema\\\/person\\\/ead9dbae0b7c930f3c8f361f35835f9b\"},\"description\":\"icotec ag is proud to announce the completion of 50 % patient enrollment for its ongoing multi-center post-market clinical follow-up (PMCF) study with the KONG\u00ae-TL VBR System.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.icotec-medical.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/PMCF-scaled-e1686321396601.jpg\",\"contentUrl\":\"https:\\\/\\\/www.icotec-medical.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/PMCF-scaled-e1686321396601.jpg\",\"width\":2133,\"height\":2560,\"caption\":\"PMCF\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2023-06-01: Completion of 50 % patient enrollment for PMCF study with the KONG\u00ae-TL VBR System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/#website\",\"url\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/\",\"name\":\"icotec\",\"description\":\"Innovative Implantate aus kohlefaserverst\u00e4rktem Kunststoff\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/#\\\/schema\\\/person\\\/ead9dbae0b7c930f3c8f361f35835f9b\",\"name\":\"Nicole Heim\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/05b86223de548b293a580dc0f3a84f93581d63daf1a4a098e3fac58785fe95c8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/05b86223de548b293a580dc0f3a84f93581d63daf1a4a098e3fac58785fe95c8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/05b86223de548b293a580dc0f3a84f93581d63daf1a4a098e3fac58785fe95c8?s=96&d=mm&r=g\",\"caption\":\"Nicole Heim\"},\"sameAs\":[\"http:\\\/\\\/www.icotec-medical.com\"],\"url\":\"https:\\\/\\\/www.icotec-medical.com\\\/en-us\\\/news\\\/author\\\/078f577fc8ac398e\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Completion of 50% for the PMCF study with the KONG\u00ae-TL VBR system | icotec","description":"icotec ag is proud to announce the completion of 50 % patient enrollment for its ongoing multi-center post-market clinical follow-up (PMCF) study with the KONG\u00ae-TL VBR System.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/","og_locale":"en_US","og_type":"article","og_title":"Completion of 50% for the PMCF study with the KONG\u00ae-TL VBR system | icotec","og_description":"icotec ag is proud to announce the completion of 50 % patient enrollment for its ongoing multi-center post-market clinical follow-up (PMCF) study with the KONG\u00ae-TL VBR System.","og_url":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/","og_site_name":"icotec","article_published_time":"2023-06-05T06:01:00+00:00","article_modified_time":"2023-06-09T14:42:05+00:00","og_image":[{"width":2131,"height":1068,"url":"https:\/\/www.icotec-medical.com\/wp-content\/uploads\/2023\/06\/PMCF-scaled-e1686321396601.jpg","type":"image\/jpeg"}],"author":"Nicole Heim","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nicole Heim","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/#article","isPartOf":{"@id":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/"},"author":{"name":"Nicole Heim","@id":"https:\/\/www.icotec-medical.com\/en-us\/#\/schema\/person\/ead9dbae0b7c930f3c8f361f35835f9b"},"headline":"2023-06-01: Completion of 50 % patient enrollment for PMCF study with the KONG\u00ae-TL VBR System","datePublished":"2023-06-05T06:01:00+00:00","dateModified":"2023-06-09T14:42:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/"},"wordCount":279,"commentCount":0,"image":{"@id":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.icotec-medical.com\/wp-content\/uploads\/2023\/06\/PMCF-scaled-e1686321396601.jpg","articleSection":["Unkategorisiert"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/","url":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/","name":"Completion of 50% for the PMCF study with the KONG\u00ae-TL VBR system | icotec","isPartOf":{"@id":"https:\/\/www.icotec-medical.com\/en-us\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/#primaryimage"},"image":{"@id":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.icotec-medical.com\/wp-content\/uploads\/2023\/06\/PMCF-scaled-e1686321396601.jpg","datePublished":"2023-06-05T06:01:00+00:00","dateModified":"2023-06-09T14:42:05+00:00","author":{"@id":"https:\/\/www.icotec-medical.com\/en-us\/#\/schema\/person\/ead9dbae0b7c930f3c8f361f35835f9b"},"description":"icotec ag is proud to announce the completion of 50 % patient enrollment for its ongoing multi-center post-market clinical follow-up (PMCF) study with the KONG\u00ae-TL VBR System.","breadcrumb":{"@id":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/#primaryimage","url":"https:\/\/www.icotec-medical.com\/wp-content\/uploads\/2023\/06\/PMCF-scaled-e1686321396601.jpg","contentUrl":"https:\/\/www.icotec-medical.com\/wp-content\/uploads\/2023\/06\/PMCF-scaled-e1686321396601.jpg","width":2133,"height":2560,"caption":"PMCF"},{"@type":"BreadcrumbList","@id":"https:\/\/www.icotec-medical.com\/en-us\/news\/2023-06-01-completion-of-50-patient-enrollment-for-pmcf-study-with-the-kong-tl-vbr-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.icotec-medical.com\/en-us\/"},{"@type":"ListItem","position":2,"name":"2023-06-01: Completion of 50 % patient enrollment for PMCF study with the KONG\u00ae-TL VBR System"}]},{"@type":"WebSite","@id":"https:\/\/www.icotec-medical.com\/en-us\/#website","url":"https:\/\/www.icotec-medical.com\/en-us\/","name":"icotec","description":"Innovative Implantate aus kohlefaserverst\u00e4rktem Kunststoff","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.icotec-medical.com\/en-us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.icotec-medical.com\/en-us\/#\/schema\/person\/ead9dbae0b7c930f3c8f361f35835f9b","name":"Nicole Heim","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/05b86223de548b293a580dc0f3a84f93581d63daf1a4a098e3fac58785fe95c8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/05b86223de548b293a580dc0f3a84f93581d63daf1a4a098e3fac58785fe95c8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/05b86223de548b293a580dc0f3a84f93581d63daf1a4a098e3fac58785fe95c8?s=96&d=mm&r=g","caption":"Nicole Heim"},"sameAs":["http:\/\/www.icotec-medical.com"],"url":"https:\/\/www.icotec-medical.com\/en-us\/news\/author\/078f577fc8ac398e\/"}]}},"_links":{"self":[{"href":"https:\/\/www.icotec-medical.com\/en-us\/wp-json\/wp\/v2\/posts\/4892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icotec-medical.com\/en-us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icotec-medical.com\/en-us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icotec-medical.com\/en-us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icotec-medical.com\/en-us\/wp-json\/wp\/v2\/comments?post=4892"}],"version-history":[{"count":0,"href":"https:\/\/www.icotec-medical.com\/en-us\/wp-json\/wp\/v2\/posts\/4892\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.icotec-medical.com\/en-us\/wp-json\/wp\/v2\/media\/4883"}],"wp:attachment":[{"href":"https:\/\/www.icotec-medical.com\/en-us\/wp-json\/wp\/v2\/media?parent=4892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icotec-medical.com\/en-us\/wp-json\/wp\/v2\/categories?post=4892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icotec-medical.com\/en-us\/wp-json\/wp\/v2\/tags?post=4892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}